FindTrial
Sign In

Evaluation of the effectiveness of endoscopic screening and early diagnosis and treatment in prevention of upper gastrointestinal cancer in high risk areas in China

Evaluation of the effectiveness of endoscopic screening and early diagnosis and treatment in prevention of upper gastrointestinal cancer in high risk areas in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017163
Enrollment
Unknown
Registered
2018-07-15
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper-gastrointestinal cancer

Interventions

Screening group:Endoscopic examination
Non-screening group:Health education
Control group:None

Sponsors

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 69 Years

Inclusion criteria

Inclusion criteria: Criteria for inclusion of study center: 1) locating at pilot areas that started upper gastrointestinal cancer screening early in 2005 or 2006; 2) representing different economical-geographical regions in China; 3) had routinely collected and reported cancer follow-up data. The inclusion criteria for participants: 1) permanent residents in the target areas; 2) aged 40-69 years; 3) willing to participate and competent to provide written informed consent.

Exclusion criteria

Exclusion criteria: Contraindications for endoscopic screening (e.g. allergy to iodine solution or lidocaine).

Design outcomes

Primary

MeasureTime frame
Incidence;Mortality;—

Countries

China

Contacts

Public ContactWang Guiqi, Wei Wenqiang
weiwq@cicams.ac.cn+86 010-87788661

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026